期刊文献+

甲状腺激素受体:非酒精性脂肪性肝病的新靶点 被引量:3

Thyroid hormone receptor:a new target of nonalcoholic fatty liver disease
原文传递
导出
摘要 甲状腺激素(TH)是维持正常代谢的重要激素,甲状腺激素受体(TR)及其亚型的分布在不同组织起着不同的作用,其中TRβ参与了脂代谢并主要作用于肝脏。TH与高血脂、肥胖、胰岛素抵抗及非酒精性脂肪性肝病(NAFLD)的发生密不可分。TRcL抑制剂、TRβ激动剂及TH类似物均显示出了对NAFLD的治疗作用。 Thyroid hormone(TH) is an important hormone for maintaining normal metabolism, thyroid hormone receptor (TR) and its isoforms distribute in different tissues with different effects.TRβ acts mainly in liver and participates in lipid metabolism.TH is closely associated with hyperlipemia, obesity,insulin resistance and nonalcoholic fatty liver disease (NAFLD). TRβ antagonist,TRβ agonist and TH analogue show therapeutic effects of NAFLD.
作者 黄玥晔 曲伸
出处 《国际内分泌代谢杂志》 北大核心 2014年第1期43-45,共3页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(81070238) 中华医学会临床医学科研专项资金(12020550355)
关键词 甲状腺激素 甲状腺激素受体 非酒精性脂肪性肝病 肥胖 Thyroid hormone Thyroid hormone receptor Nonalcoholic fatty liver disease Obesity
  • 相关文献

参考文献25

  • 1Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol, 2009,50( 1 ):204-210.
  • 2Cable EE,Finn PD,Stebbins JW,et al.Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist [J].Hepatology, 2009,49 (2) : 407-417.
  • 3Adams AC, Astapova I, Fisher FM, et al.Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner[J].J Biol Chem, 2010,285 (19) : 14078-14082.
  • 4Musso G, Gambino R, Cassader M.Emerging molecular targets for the treatment of nonalcoholic fatty liver disease[J].Annu Rev Med,2010,61:375-392.
  • 5Almeda- Valdes P, Cuevas - Ramos D, Aguilar- Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease[J].Ann Hepatol,2009,8 (Suppl 1 ) :S18-S24.
  • 6Chen SH,He F,Zhou HL,et al.Relationship between nonalco- holic fatty liver disease and metabolic syndrome[J].J Dig Dis, 2011,12( 2): 125-130.
  • 7Erdogan M, Canataroglu A, Ganidagli S, et al.Metabolic syndrome prevalence in subelinie and overt hypothyroid patients and the relation among metabolic syndrome parameters[J].J Endocrinol Invest, 2011,34(7 ) : 488-492.
  • 8Mazo DF,Lima VM,Stefano JT,et al.Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease[J].Arq Gastroentero1,2011,48(3 ) : 186-189.
  • 9Gnoni GV, Rochira A, Leone A, et al.3,5,3'triiodo-L-thyronine induces SREBP-1 expression by non-genomic actions in human I-IEP G2 cells[J].J Cell Physiol, 2012,227( 6 ) :2388-2397.
  • 10Perra A,Simbula G,Simbula M,et al.Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats[J].FASEB J, 2008,22( 8 ) : 2981-2989.

同被引文献11

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部